Harima B.Stem Corporation
Notice Regarding the Status of Share Buyback
Discloses the status including unpurchased shares. Total purchased shares: 0 shares, total amount: 0 yen, acquisition period: July 1–31, 2026 (trade date basis), acquisition method: market purchase on the Tokyo Stock Exchange. For reference, the decision announced on February 6, 2026 set a cap of 400,000 shares and 300,000,000 yen, and as of July 31, 2026 progress was 306,900 shares and 292,321,100 yen.
Key Figures
- Total number of shares acquired: 0 shares
- Total acquisition amount: 0 yen
- Progress as of July 31, 2026: 306,900 shares / 292,321,100 yen
AI要約
Acquisition status overview
The disclosed status of the share buyback announced today shows the share type as common stock, total shares acquired as 0, total acquisition amount as 0 yen, acquisition period from July 1 to July 31, 2026 (trade-date basis), and acquisition method as a market purchase on the Tokyo Stock Exchange, with no actual acquisitions to date. As reference, the February 6, 2026 disclosure stated a cap of 400,000 shares and 300 million yen, with the period from February 6, 2026 to February 5, 2027; as of July 31, 2026, progress was 306,900 shares and approximately 292,320,100 yen.
Impact on investors and future outlook
This disclosure aims to increase transparency of the share buyback progress. At present, no acquisitions have been made, so dilution-prevention effects are not yet realized, but the upper limit and period remain clearly set, and future buybacks are expected. The market-purchase method is subject to market conditions, and progress could be material for shareholder returns if acquisitions proceed.
Harima Biostem Co., Ltd.
Company overview · Stock price · Financial data · All IR
